Cargando…
Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease
Parkinson's disease (PD) is the most common movement disorder disease in the elderly and is characterized by degeneration of dopamine neurons and formation of Lewy bodies. Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS). If glutamate is not removed promptl...
Autores principales: | Zhang, Yunlong, Tan, Feng, Xu, Pingyi, Qu, Shaogang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769779/ https://www.ncbi.nlm.nih.gov/pubmed/26981287 http://dx.doi.org/10.1155/2016/8941327 |
Ejemplares similares
-
Excitatory Amino Acid Transporters (EAATs): Glutamate Transport and Beyond
por: Magi, Simona, et al.
Publicado: (2019) -
Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease
por: Zhang, Yunlong, et al.
Publicado: (2017) -
Blood neuroexosomal excitatory amino acid transporter-2 is associated with cognitive decline in Parkinson’s disease with RBD
por: Leng, Bing, et al.
Publicado: (2022) -
Structure and allosteric inhibition of excitatory amino acid
transporter 1
por: Canul-Tec, Juan C., et al.
Publicado: (2017) -
Cysteine Transport through Excitatory Amino Acid Transporter 3 (EAAT3)
por: Watts, Spencer D., et al.
Publicado: (2014)